.png "Lupin's LMS and PolyPeptide Form Alliance to Strengthen Peptide Supply")
Lupin Manufacturing Solutions (LMS), a subsidiary of Lupin Limited, announced a major strategic alliance today with PolyPeptide Group AG, marking a significant move in the expanding peptide market. The long-term partnership aims to build...
Piramal Pharma drew attention today as the US FDA wrapped up a general Good Manufacturing Practices inspection at the company’s Lexington, Kentucky site. The review, held from December 3 to December 10, 2025, ended with a Form 483 containing...
Pfizer’s HER2-targeted therapy TUKYSA delivered a strong boost in first-line maintenance treatment for HER2-positive metastatic breast cancer, marking a major advance in today’s data from the Phase 3 HER2CLIMB-05 trial.
Roche has announced fresh momentum in clinical diagnostics with CE Mark approval for its new mass spectrometry reagent pack, a move that strengthens its position in mass spectrometry testing. The approval expands what is now the broadest IVD...
Alembic Pharmaceuticals has received final FDA approval for its Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, a generic version of the branded eye treatment Zylet. This achievement enhances the pipeline of U.S. generics at the...
Glenmark Pharmaceuticals announced today that its U.S. subsidiary will roll out Leucovorin Calcium for Injection USP, 350 mg/vial in December 2025. The drug is a single-dose vial and is both bioequivalent and therapeutically equivalent to...
Aon plc, a leading global professional services firm, today released the India findings from its 2026 Global Medical Trend Rates Report. The report projects that employee medical plan costs in India will rise by 11.5 percent in 2026, down from...
Maharashtra’s Food and Drug Administration (FDA) has cancelled more than 200 licences of medical retailers and wholesalers for supplying low-grade medicines, Minister of State for FDA Narhari Zirwal informed the state assembly on Wednesd..
.png "Zydus Introduces Zyrifa Biosimilar to Ease Cancer Bone Treatment")
Zydus Lifesciences Ltd. has launched Zyrifa, a 120?mg subcutaneous biosimilar of the monoclonal antibody Denosumab. The new product increases the number of cancer patients who can receive advanced treatment of bone-care which is cheape...
Cipla Limited has introduced Yurpeak (tirzepatide) in India, a once?weekly injectable therapy aimed at managing obesity and type?2 diabetes mellitus. After approval by DCGI, the company will market and sell Yurpeak the second brand of tirzepatide...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")